Magnetar Capital

Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 17
Average round size
The average size of a deal this fund participated in
Portfolio companies 15
Rounds per year 1.00
Lead investments 4
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees 2

Areas of investment

  • Health Care
  • Biotechnology
  • Medical Device
  • Therapeutics
  • Energy

Magnetar Capital appeared to be the VC, which was created in 2005. The company was established in North America in United States. The main department of described VC is located in the Evanston.

Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2016. Despite it in 2019 the fund had an activity. Opposing the other organizations, this Magnetar Capital works on 4 percentage points less the average amount of lead investments. The increased amount of exits for fund were in 2003. The real fund results show that this VC is 5 percentage points more often commits exit comparing to other companies.

Besides them, we counted 2 critical employees of this fund in our database.

The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Life Science. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight SurgRx, Inc, Fountainhead Commercial Capital, Kintera.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Magnetar Capital, startups are often financed by Wells Fargo Securities, California Technology Ventures, Cadence Bancorp. The meaningful sponsors for the fund in investment in the same round are Wanxiang Healthcare Investments, WS Investments, Trellis Health Ventures. In the next rounds fund is usually obtained by Prospect Venture Partners, New Enterprise Associates, Alta Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Magnetar Capital:
Typical Co-investors
Magnetar Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Magnetar Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aurora Capital Partners California, Los Angeles, United States
Boyaruide Beijing, China, Haidian
Kashiwabara Japan, Minato
Learning Technologies Group Brighton, East Sussex, United Kingdom
LG Venture Investment Seoul, Seoul-t'ukpyolsi, South Korea
MedTech Venture Partners California, San Francisco, United States
Rein Capital Lakewood, New Jersey, United States
SL Ventures New Jersey, United States, Wyckoff
Weta Digital New Zealand, Wellington, Wellington
Where Angels Fund -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Enable Injections

Health Care
Life Science
Medical Device
$215M27 Jan 2022 Cincinnati, Ohio, United States


Clean Energy
Energy Efficiency
Renewable Energy
$100M05 Jan 2022 Louisiana, United States


Cloud Computing
Information Technology
Machine Learning
$50M10 Nov 2021 New York, New York, United States

Comtech Telecommunications

Developer Platform
Information Technology
Public Relations
$100M18 Oct 2021 New York, United States

Activ Surgical

Artificial Intelligence
Health Care
Machine Learning
Medical Device
$45M30 Sep 2021 Boston, Massachusetts, United States

Vedanta Biosciences

Business Development
Drug Discovery
$43M21 Jul 2021 Cambridge, Massachusetts, United States

Evolv Technology

Artificial Intelligence
Intrusion Detection
Machine Learning
Physical Security
$300M19 Jul 2021 Massachusetts, United States


Health Care
$40M31 Mar 2021 Seattle, Washington, United States

Judo Bank

Financial Services
$207M23 Dec 2020 Victoria
Vedanta Biosciences Raises $68M in Series D Financing

– Vedanta Biosciences, Inc. from Cambridge, MA develops new category of oral therapies using defined bacterial consortia manufactured from clonal cell banks.
– The company closed a $68m Series D financing.
– The round was led by affiliates of Magnetar Capital with participation from Verition Fund Management, Fosun Health Capital, co-founder PureTech Health (Nasdaq: PRTC, LSE: PRTC), Rock Springs Capital, Skyviews Life Science, JSR Corporation, SymBiosis LLC, Shumway Capital, Health for Life Capital (Seventure Partners), and other institutional investors.
– The company plans to use the funds to advance its pipeline of defined bacterial consortia, including progressing VE303 into a Phase 3 clinical trial in patients at high risk for recurrentCDI, initiating a Phase 2 clinical trial of VE202 in mild to moderate ulcerative colitis, and continuing to advance programs in additional indications.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Magnetar Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: